Operations have started at the first unit of the South Korean-built Barakah nuclear power plant in the United Arab Emirates (UAE).
Dubai's ruler Sheikh Mohammed bin Rashid al-Maktoum announced via Twitter that nuclear fuel was successfully loaded into the Barakah nuclear plant's first reactor, completed by a South Korean-led consortium in 2018.
The said nuclear reactor was among the four that the consortium committed to building in 2009 for US$20 billion.
The three other reactors are under construction.
The combined output of the Barakah nuclear plant's four reactors is 5,600 megawatts, enough to supply up to 25 percent of the UAE's electricity requirement.
The project was South Korea's first export of its homegrown commercial atomic power technology.
Last year, the South Korean consortium was awarded a five-year maintenance contract for the Barakah nuclear plant.
The deal includes providing maintenance services and an experienced workforce to Nawah Energy Co., the nuclear plant's operator.


REPAY Stock Rises After Visa Platform Connect Collaboration
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
Standard Chartered Expands Hedge Fund Access for Wealth Clients
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook 



